A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer
Clinical trial NCT07543471 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07543471
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-06-30
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.